Companies that have significant growth prospects for profitability and returns can add tangible upside to your portfolio. YouGov and Bilby are examples of many potential outperformers that analysts are bullish on. Whether it be a well-known tech stock or a risky small-cap, I believe diversification towards growth can add value to your current holdings. Below I’ve compiled a list of stocks with a bright future ahead.

YouGov plc (AIM:YOU)

YouGov plc provides online market research services in the United Kingdom, the United States, Germany, the Nordic countries, the Middle East, France, and the Asia Pacific. Started in 2000, and currently headed by CEO Stephan Shakespeare, the company provides employment to 779 people and with the market cap of GBP £401.72M, it falls under the small-cap stocks category.

YOU’s forecasted bottom line growth is an optimistic 35.45%, driven by the underlying double-digit sales growth of 19.78% over the next few years. Although reduction in cost is not the most sustainable operational activity, the expanding top-line growth, on the other hand, is encouraging. Moreover, the 45.88% growth in operating cash flows shows that a decent part of earnings is driven by robust cash generation from operational activities, not one-off or non-core activities. YOU’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Want to know more about YOU? I recommend researching its fundamentals here.

Bilby Plc (AIM:BILB)

Bilby Plc, through its subsidiaries, provides gas heating and general building services to housing associations, local authorities, and domestic customers in London and the South East. Established in 2014, and currently run by , the company size now stands at 300 people and with the market cap of GBP £39.69M, it falls under the small-cap stocks category.

A potential addition to your portfolio? Have a browse through its key fundamentals here.

Oncimmune Holdings Plc (AIM:ONC)

Oncimmune Holdings Plc, an early cancer detection company, develops and commercializes products to diagnose cancer in the United Kingdom and North America. Founded in 2015, and now led by CEO Geoffrey Hamilton-Fairley, the company employs 47 people and with the company’s market capitalisation at GBP £82.69M, we can put it in the small-cap stocks category.

Extreme optimism for ONC, as market analysts projected an outstanding earnings growth rate of 73.09% for the stock, supported by an equally strong sales. It appears that ONC’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. Moreover, the 45.14% growth in operating cash flows shows that a decent part of earnings is driven by robust cash generation from operational activities, not one-off or non-core activities. ONC’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Could this stock be your next pick? Other fundamental factors you should also consider can be found here.